Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy

References

• Strachan DP. Hay fever, hygiene, and household size. BMJ (Clinical Research Ed); 299:1259–60.
   Google Scholar
• Hertzen LC. The hygiene hypothesis in the development of atopy and asthma--still a matter of controversy?. QJM 1998; 91:767 - 71; http://dx.doi.org/10.1093/qjmed/91.11.767; PMID: 10024940
   PubMedGoogle Scholar
• Strachan DP. Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax 2000; 55:Suppl 1 S2 - 10; http://dx.doi.org/10.1136/thorax.55.suppl_1.S2; PMID: 10943631
   PubMed Web of Science ®Google Scholar
• Okada H, Kuhn C, Feillet H, Bach J-F. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010; 160:1 - 9; http://dx.doi.org/10.1111/j.1365-2249.2010.04139.x; PMID: 20415844
   PubMed Web of Science ®Google Scholar
• Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?. Immunology 2004; 112:352 - 63; http://dx.doi.org/10.1111/j.1365-2567.2004.01925.x; PMID: 15196202
   PubMed Web of Science ®Google Scholar
• Bilenki L, Gao X, Wang S, Yang J, Fan Y, Han X, Qiu H, Yang X. Dendritic cells from mycobacteria-infected mice inhibits established allergic airway inflammatory responses to ragweed via IL-10- and IL-12-secreting mechanisms. J Immunol 2010; 184:7288 - 96; http://dx.doi.org/10.4049/jimmunol.0902829; PMID: 20483754
   PubMed Web of Science ®Google Scholar
• Rona RJ, Keil T, Summers C, Gislason D, Zuidmeer L, Sodergren E, Sigurdardottir ST. The prevalence of food allergy : a meta-analysis. J Allergy Clin Immunol. 2007;120(3):638-46
   Google Scholar
• Daser A, Meissner N, Herz U, Renz H. Role and modulation of T-cell cytokines in allergy. Curr Opin Immunol 1995; 7:762 - 70; http://dx.doi.org/10.1016/0952-7915(95)80045-X; PMID: 8679117
   PubMed Web of Science ®Google Scholar
• Gieni RS, Yang X, HayGlass KT. Allergen-specific modulation of cytokine synthesis patterns and IgE responses in vivo with chemically modified allergen. J Immunol 1993; 150:302 - 10; PMID: 7678032
   PubMed Web of Science ®Google Scholar
• Kitagaki K, Businga TR, Kline JN. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice. Clin Exp Immunol 2006; 143:249 - 59; http://dx.doi.org/10.1111/j.1365-2249.2005.03003.x; PMID: 16412048
   PubMed Web of Science ®Google Scholar
• Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, Ibañez AE, Barrionuevo P, Oliveira FS, Carvalho NB, Borkowski J, et al. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis. J Immunol 2010; 184:5200 - 12; http://dx.doi.org/10.4049/jimmunol.0902209; PMID: 20351187
   PubMed Web of Science ®Google Scholar
• Ibañez AE, Smaldini P, Coria LM, Delpino MV, Pacífico LGG, Oliveira SC, Risso GS, Pasquevich KA, Fossati CA, Giambartolomei GH, et al. Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow’s milk proteins. PLoS One 2013; 8:e69438; http://dx.doi.org/10.1371/journal.pone.0069438; PMID: 23861971
   PubMed Web of Science ®Google Scholar
• Boutajangout A, Goni F, Knudsen E, Schreiber F, Quartermain D, Frangione B, Chabalgoity A, Sigurdsson EM. Diminished amyloid-beta burden in Tg2576 Mice Following a Prophylactic Oral Immunization with a Salmonella-based Aβ Derivative Vaccine. J Alzheimers Dis 2009; 18:961 - 72; PMID: 19749432
   PubMed Web of Science ®Google Scholar
• Moingeon P, Lombardi V, Saint-Lu N, Tourdot S, Bodo V, Mascarell L. Adjuvants and vector systems for allergy vaccines. Immunol Allergy Clin North Am 2011; 31:407 - 19, xii; http://dx.doi.org/10.1016/j.iac.2011.03.001; PMID: 21530828
   PubMed Web of Science ®Google Scholar
• Nguyen CT, Hong SH, Ung TT, Verma V, Kim SY, Rhee JH, Lee SE. Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model. Clin Exp Vaccine Res 2013; 2:128 - 34; http://dx.doi.org/10.7774/cevr.2013.2.2.128; PMID: 23858404
   PubMedGoogle Scholar
• Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006; 6:148 - 58; http://dx.doi.org/10.1038/nri1777; PMID: 16491139
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11:Suppl S45 - 53; http://dx.doi.org/10.1038/nm1213; PMID: 15812489
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Kool M, Willart MA, Hammad H. Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 2009; 21:23 - 9; http://dx.doi.org/10.1016/j.coi.2009.01.004; PMID: 19246182
   PubMed Web of Science ®Google Scholar
• Blaas SH, Stieber-Gunckel M, Falk W, Obermeier F, Rogler G. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells. Clin Exp Immunol 2009; 155:534 - 40; http://dx.doi.org/10.1111/j.1365-2249.2008.03855.x; PMID: 19220839
   PubMed Web of Science ®Google Scholar
• Beeh K-M, Kanniess F, Wagner F, Schilder C, Naudts I, Hammann-Haenni A, Willers J, Stocker H, Mueller P, Bachmann MF, et al. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. J Allergy Clin Immunol 2013; 131:866 - 74; http://dx.doi.org/10.1016/j.jaci.2012.12.1561; PMID: 23384679
   PubMed Web of Science ®Google Scholar
• Malyala P, Chesko J, Ugozzoli M, Goodsell A, Zhou F, Vajdy M, O’Hagan DT, Singh M. The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. J Pharm Sci 2008; 97:1155 - 64; http://dx.doi.org/10.1002/jps.21065; PMID: 17683059
   PubMed Web of Science ®Google Scholar
• Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, Nishiyama M, Sato S, Tsujimura T, Yamamoto M, Yokota Y, et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol 2008; 9:769 - 76; http://dx.doi.org/10.1038/ni.1622; PMID: 18516037
   PubMed Web of Science ®Google Scholar
• Broide DH, Stachnick G, Castaneda D, Nayar J, Miller M, Cho JY, Roman M, Zubeldia J, Hayashi T, Raz E. Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J Clin Immunol 2001; 21:175 - 82; http://dx.doi.org/10.1023/A:1011078930363; PMID: 11403224
   PubMed Web of Science ®Google Scholar
• Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Spiegelberg HL, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000; 106:124 - 34; http://dx.doi.org/10.1067/mai.2000.107927; PMID: 10887315
   PubMed Web of Science ®Google Scholar
• Shirota H, Sano K, Kikuchi T, Tamura G, Shirato K. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 2000; 164:5575 - 82; http://dx.doi.org/10.4049/jimmunol.164.11.5575; PMID: 10820231
   PubMed Web of Science ®Google Scholar
• Teshima R, Okunuki H, Sato Y, Akiyama H, Maitani T, Sawada J. Effect of oral administration of CpG ODN-OVA on WBB6F1-W/Wv mice. Allergol Int. 2006; 55:43–8
   Google Scholar
• Weiss R, Scheiblhofer S, Thalhamer J. Allergens are not pathogens: Why immunization against allergy differs from vaccination against infectious diseases. Hum Vaccin Immunother 2013; 10:10; PMID: 24280693
   PubMed Web of Science ®Google Scholar
• Klimek L, Willers J, Hammann-Haenni A, Pfaar O, Stocker H, Mueller P, Renner WA, Bachmann MF. Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. Clin Exp Allergy 2011; 41:1305 - 12; http://dx.doi.org/10.1111/j.1365-2222.2011.03783.x; PMID: 21672053
   PubMed Web of Science ®Google Scholar
• Fujihashi K, Koga T, van Ginkel FW, Hagiwara Y, McGhee JR. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 2002; 20:2431 - 8; http://dx.doi.org/10.1016/S0264-410X(02)00155-X; PMID: 12057597
   PubMed Web of Science ®Google Scholar
• Glueck R. Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization. Vaccine 2001; 20:Suppl 1 S42 - 4; http://dx.doi.org/10.1016/S0264-410X(01)00292-4; PMID: 11587809
   PubMed Web of Science ®Google Scholar
• Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med 2004; 350:896 - 903; http://dx.doi.org/10.1056/NEJMoa030595; PMID: 14985487
   PubMed Web of Science ®Google Scholar
• Levine MM, Black RE, Clements ML, Lanata C, Sears S, Honda T, Young CR, Finkelstein RA. Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun 1984; 43:515 - 22; PMID: 6693169
   PubMed Web of Science ®Google Scholar
• Smaldini P, Curciarello R, Candreva A, Rey MA, Fossati CA, Petruccelli S, Docena GH. In vivo evidence of cross-reactivity between cow’s milk and soybean proteins in a mouse model of food allergy. Int Arch Allergy Immunol 2012; 158:335 - 46; http://dx.doi.org/10.1159/000333562; PMID: 22472742
   PubMed Web of Science ®Google Scholar